ArticleScientific reports2024
Transcutaneous intravascular laser irradiation of blood affects plasma metabolites of women.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical applications and molecular mechanisms for intravenous laser blood irradiation: a systematic review.Lasers in medical science · 2025Pooled it
- Potential Effect of Intravascular Laser Irradiation of Blood (ILIB) in Improving Physical Performance: A Narrative Review.Journal of functional morphology and kinesiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The effectiveness of indirect Intravascular laser irradiation of blood (ILIB) is not fully understood. In this study, we provided a novel experiment that employs metabolomics to investigate the effects of ILIB in women. Twenty-eight volunteers underwent indirect ILIB and had their plasma collected before and after this procedure. The ILIB was applied at the radial artery for 30 min, using low-power photobiomodulation (660 nm), and a power output of 0.1 W. Plasma samples were extracted and analyzed using liquid chromatography-high-resolution mass spectrometry in an untargeted approach. Partial Least Squares Discriminant Analysis revealed 151 molecules with the Variable In Projection score of ≥ 1. From these, 26 were identified. After checking for molecules related to dietary intake, fasting, medication, or part of the human exposome, 15 were affected by ILIB. The abundances of Estradiol 17b-glucuronide 3-sulfate, CAR 14:3, PI 22:6/PGJ2, and CAR 12:1 significantly increased by ILIB, while AcylGlcADG 62:9, Tyrosyl-Glutamine, and CDP-DG 22:3/PGF1 had the contrary effect. ILIB was shown to modulate molecules from different chemical classes, although its impact on plasma metaboloma was minimal. Further research is warranted to fully elucidate the implications of these findings across various metabolic pathways, thus advancing the science surrounding ILIB.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.